Tokyo Finance (531644)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/B at 1.34 means the price is not wildly detached from tangible book value of ₹16.33.
• ROCE of 2.01%, though low, is positive and suggests some capital is earning a small return.
• Current price is below the 52-week midpoint of ₹24.01, so there is no obvious speculative froth.
• Tiny ₹16 Cr market cap leaves room for a potential balance-sheet unlock if book value is genuine.

Concerns

• Latest quarter shows zero sales and zero net profit, leaving the business with no current earning power.
• ROE of 0.26% and profit growth of -44.44% mean equity capital is being put to dismal use.
• Piotroski F-score of 3/9 indicates weak financial health and poor operating fundamentals.
• No dividend, unknown promoter holding, and insufficient FairStock data create a serious lack of transparency.

AI Analysis

At first glance, a P/E of 242.83 tells me not to trust earnings, because there are hardly any. Tokyo Finance is a ₹16-crore micro-cap NBFC with a book value of ₹16.33 per share, yet it is priced at ₹21.92. That is 1.34 times book. For that premium, what is the investor getting? ROE is just 0.26%, ROCE is 2.01%, profit growth is down 44.44%, and the latest quarter shows zero sales and zero net profit. No dividend. No visible earnings power. The Piotroski F-score of 3/9 only reinforces my suspicion that the financial health is poor. As Graham would say, the stock market is not a voting machine in the long run; it is a weighing machine. But what is there to weigh here? A tiny balance sheet, a negligible return on equity, and no indication of a moat. This is not a wonderful business at a fair price. It is a poor business at a price above book. The 52-week range of ₹17.15 to ₹30.88 suggests a speculative, thinly traded stock, not a stable compounding machine. Promoter holding is unavailable, and the FairStock score is insufficient — meaning I am being asked to invest without adequate information. I don't do that. Could this be an asset play? Perhaps, if the investments on the balance sheet are sound and the stock trades at a meaningful discount to book value. At ₹21.92, no such discount exists. I need a margin of safety. I would rather keep my capital in a fixed deposit than earn 0.26% ROE while taking equity risk. The only thing that would get me interested is a price well below ₹16.33 book value, or concrete evidence of a genuine business recovery. Without that, this is a pass. In investing, sometimes the best action is to say no and read the next annual report.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer